	Capital Y Las Reservas		Fecha
Acadia Pharmaceuticals	USD 917.27M	94.89M	2025-09
Agios Pharmaceuticals	USD 1.19B	91.22M	2025-12
Alnylam Pharmaceuticals	USD 789.18M	555.28M	2025-12
Amarin	USD 458.89M	6.03M	2025-09
Amgen	USD 8.66B	961M	2025-12
Baxter International	USD 6.13B	1.11B	2025-12
Cara Therapeutics	USD 32.93M	41M	2025-06
Cytokinetics	USD -659.62M	138.5M	2025-12
DBV Technologies	USD 52.85M	33.37M	2025-09
Eli Lilly	USD 26.54B	2.74B	2025-12
Esperion Therapeutics	USD -451.36M	17.85M	2025-09
Halozyme Therapeutics	USD 48.81M	455.1M	2025-12
Intrexon	USD 43.17M	75.33M	2024-06
Ionis Pharmaceuticals	USD 617.97M	13.76M	2025-09
MannKind	USD -51.02M	6.47M	2025-12
Minerva Neurosciences	USD -34.58M	2.47M	2025-09
Nektar Therapeutics	USD 85.09M	109.3M	2025-09
Pfizer	USD 92.8B	4.11B	2025-09
Rigel Pharmaceuticals	USD 117.61M	35.67M	2025-09
United Therapeutics	USD 7.1B	506M	2025-12
Vanda Pharmaceuticals	USD 327.19M	138.81M	2025-12

Halozyme Therapeutics Capital Y Las Reservas - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Mar 2026.